| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 11/14/2016 | 5:04PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 11/14/2016 | 4:04PM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Third Quarter 2016 Financial Results | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 11/10/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Signs Agreement with Specialty Pharmacy Division of One of the Nation's Largest Pharmacy Benefit Man... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 11/09/2016 | 5:16PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 11/03/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals to Host its Third Quarter 2016 Financial Report | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 11/03/2016 | 6:14AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/28/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Registers its New Jersey Facility with the FDA as an Outsourcing Facility | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/25/2016 | 8:30AM | PR Newswire (US) | Imprimis' Dropless Therapy Shows Significant Advantages in a Large Peer-Reviewed Study | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/17/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Availability of Lower-Cost Option for the Treatment of Lead Poisoning | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/13/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals' Formulations to be Highlighted at Upcoming Annual Ophthalmology Meeting in Chicago | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/06/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals' CEO Mark L. Baum to Debate at the Oxford Union Debating Society | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/26/2016 | 5:01PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/26/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Accelerates Profitability Timeline by Implementing Expense Reduction Program | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/22/2016 | 8:30AM | PR Newswire (US) | Following Congressional Hearing Investigating Mylan and Epi-Pen, Imprimis Pharmaceuticals Founder and CEO Publishes Drug Pric... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/14/2016 | 8:02AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/06/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Launches Imprimis Cares Access Network (ICAN) to Assist in Patient Access to Imprimis Cares® Compou... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/30/2016 | 6:11AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/15/2016 | 4:08PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/15/2016 | 4:07PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/15/2016 | 4:03PM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Second Quarter 2016 Financial Results | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/15/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Strengthens Senior Leadership Team with Key Hires in Operations, Quality, Manufacturing and Client R... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/11/2016 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/11/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Announces $2 Million Equipment Sale Leaseback Agreement with Essex Capital Corporation | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/01/2016 | 9:00AM | PR Newswire (US) | Imprimis Pharmaceuticals to Host its Second Quarter 2016 Financial Report Conference Call and Webcast on August 15, 2016 at 4... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/29/2016 | 9:00AM | PR Newswire (US) | Imprimis Launches New MaxRx Prescriber Portal™ | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/22/2016 | 9:00AM | PR Newswire (US) | Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/17/2016 | 5:26PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/15/2016 | 6:08AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/14/2016 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |